(:APH*CA)

Business Focus: N/A

Nov 02, 2018 02:34 pm ET

Aphria Announces Promotion of Jakob Ripshtein to President

LEAMINGTON, ON, Nov. 2, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) announced the promotion of Jakob Ripshtein to President of the Company, effective today. As President, Ripshtein will continue to report to the Chief Executive Officer and have responsibility for the Company's operating units worldwide.

Nov 02, 2018 07:30 am ET

Innovative Cannabis Delivery Technologies on the Rise: The Greater Cannabis Company, Inc. (OTC: GCAN), Aphria, Tilray, Aurora and Canopy Growth

Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on new and innovative delivery systems coming to market. Through the month of September, larger Canadian...

Nov 01, 2018 11:43 pm ET

Aphria's Australian-Based Partner Althea Granted Manufacture Licence

LEAMINGTON, ON, Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control.

Oct 30, 2018 07:00 am ET

Aphria to commence trading on the NYSE on November 2

Aphria's shares will trade on the NYSE under ticker symbol "APHA" Ticker symbol on the Toronto Stock Exchange (TSX) will also change from "APH" to "APHA" LEAMINGTON, ON, Oct. 30, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH) and (US OTC: APHQF) announced today that its common shares have been approved for listing on the New York Stock Exchange ("NYSE") and will commence trading effective the open of markets on November 2, 2018.

Oct 25, 2018 03:01 pm ET

Aphria Introduces Dr. Jonathan Simone, PhD as Director of Research and Clinical Studies

Dr. Simone is recognized for his award-winning research on the role of the endocannabinoid system in neurodevelopment, and in the regulation of affective and cognitive behaviours

Oct 25, 2018 07:30 am ET

Solar Energy and its future in the Cannabis Market; Aurora Cannabis, Solar Integrated Roofing Corporation (OTC: SIRC), Canadian Solar Inc., Aphria Inc.

Investorideas.com, a global news source covering leading sectors including both cannabis and solar stocks, issues a snapshot looking at how solar energy has and will play a key role in the future of the cannabis sector. Companies mentioned: Aurora...

Oct 17, 2018 07:00 am ET

Aphria celebrates the start of the adult-use cannabis market in Canada

Aphria's expanding portfolio of adult-use cannabis brands available to Canadians on this historic day

Oct 16, 2018 07:00 am ET

Aphria Commends UK Government on Medical Cannabis Legalization, Forms Alliance With Noted Neurologist and Leading Cannabis Advocate Professor Michael Barnes

The Company and Professor Barnes will collaborate on clinical trials to advance the applications of medical cannabis

Oct 15, 2018 07:00 am ET

Aphria completes first shipment of cannabis oil to Argentina for clinical study on treating refractory epilepsy in children

Aphria delivers 1,500 bottles of Rideau oil to its subsidiary ABP to support the advancement of clinical medical cannabis research

Oct 12, 2018 07:00 am ET

Aphria Records Solid Revenue Growth in First Quarter of 2019

35% increase in grams sold in Q1-2018 217% increase in revenue YOY Net income increases more than 40% YOY LEAMINGTON, ON, Oct. 12, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or US OTC: APHQF) today reported its results, for the first quarter and quarter ended August 31, 2018. All amounts are expressed in Canadian dollars.

Oct 11, 2018 07:00 am ET

Aphria and Drug Free Kids Canada ink charter agreement focusing on education, awareness and youth protection

LEAMINGTON, ON, Oct. 11, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH) (OTCQB: APHQF) and Drug Free Kids Canada ("Drug Free Kids" or "DFK") announced today that they have entered into a Charter Agreement (the "Agreement") focused on increasing educational awareness of the potential harms of cannabis for children and underage youth and the safe and responsible use of cannabis by adults. Aphria and Drug Free Kids are united by their shared values of keeping cannabis out of the hands of children and youth and raising awareness though effective educational campaigns. The Agreem

Oct 10, 2018 04:02 pm ET

Aphria Responds to Media Reports Re: Potential Investment

LEAMINGTON, ON, Oct. 10, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) today responded to a request from the Investment Industry Regulatory Organization of Canada ("IIROC") regarding media reports suggesting the Company is engaged in discussions regarding a potential investment in Aphria. While Aphria engages in discussions with potential strategic partners and/or investors from time to time, the Company notes that there is no agreement, understanding or arrangement in place with a potential investor at this time.

Oct 02, 2018 07:00 am ET

Aphria To Announce First Quarter Results On October 12, 2018

LEAMINGTON, ON, Oct. 2, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its first quarter results for 2019 on October 12, 2018.

Sep 28, 2018 07:00 am ET

Aphria unveils comprehensive portfolio of adult-use brands

Solei, RIFF, Good Supply, Goodfields and Broken Coast represent the Company's first wave of consumer-centric adult-use brands

Sep 27, 2018 12:02 pm ET

Scythian Biosciences Closes Strategic Sale of Latin American and Caribbean Assets

Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE: SCYB) (Frankfurt: 9SB) (OTC – Nasdaq Intl: SCCYF) has closed its strategic sale of the Company’s Latin American and Caribbean assets to Aphria Inc. (TSX:APH) (“Aphria”), a leading...

Sep 27, 2018 12:00 pm ET

Aphria Closes Acquisition of Assets in Latin America and the Carribean

Company cements foothold in the region with operations in Colombia, Argentina and Jamaica

Sep 25, 2018 08:00 am ET

Growth for Security Surveillance Technology in Cannabis Markets; Demand Driven by Compliance Regulation; Companies Mentioned: DirectView Holdings, Inc. (OTC: DIRV), Aphria Inc., Liberty Health Science

Investorideas.com, a leading investor news resource covering security and cannabis stocks releases a sector snapshot of the growing video surveillance market and how cannabis, the fastest growing sector in the world, is creating additional market...

Sep 25, 2018 07:00 am ET

Aleafia and Serruya Family to Enter Cannabis Retail Joint-Venture for Launch of One Plant™

Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), has entered into a letter of intent to acquire a 51 per cent stake in One Plant™, an adult-use cannabis retail operation led by members of the Serruya Family...

Sep 21, 2018 07:00 am ET

Aphria Appoints Head of Investor Relations

Mandate will focus on increasing ownership amongst institutional investors

Sep 20, 2018 08:05 pm ET

Aphria's Australian-Based Partner Althea Lists on the ASX in AUD$19.65M IPO

Aphria maintains 25% holding in Althea and existing supply agreement

Sep 20, 2018 02:30 pm ET

Aphria signs supply agreements with all provinces and Yukon

Aphria's adult-use cannabis products will be available coast-to-coast on October 17; introducing two new adult-use value brands in coming months

Sep 17, 2018 08:00 am ET

Scythian Biosciences Announces Successful Results of Special Meeting of Shareholders

Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl: SCCYF) is pleased to announce the results of Scythian’s special meeting of shareholders on September 14, 2018 (“Special Meeting”). At the...

Sep 14, 2018 08:00 pm ET

Aphria Announces Director Resignation and Appointment

LEAMINGTON, ON, Sept. 14, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that Dennis Staudt has resigned from the Company's Board of Directors (the "Board"). Mr. Staudt served as Lead Independent Director and Chair of the Audit Committee, and he had been a member of the Board since 2014, before the company was publicly traded.

Sep 12, 2018 08:00 am ET

Aphria Signs Wholesale Supply Agreement With Emblem Cannabis Corporation

LEAMINGTON, ON, Sept. 12, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a wholesale supply agreement with Emblem Cannabis Corp., wholly owned subsidiary of Emblem Corp. and a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations ("Emblem") to supply 175,000 kg of high-quality cannabis over a five-year period starting May 2019 (the "Agreement") with a total of 25,000 kg deliverable for the balance of the first year. Under the terms of the Agreement, Aphria will receive a

Sep 06, 2018 07:00 am ET

Aphria completes divestment of all U.S. cannabis assets with sale of remaining interest in Liberty Health Sciences

Aphria clears balance sheet of U.S. cannabis investments and will reenter U.S. market when U.S. federal laws permit

Sep 05, 2018 07:00 am ET

Aphria and Rapid Dose Therapeutics Sign MOU to Bring Innovative QuickStrip™ Oral Thin Strips to Aphria's Portfolio of Medical and Adult-Use Brands

Aphria to become RDT's exclusive Global Preferred Partner for cannabis markets

Sep 04, 2018 07:00 am ET

Aphria partners with Schroll Medical in Denmark to produce organic medical cannabis for the worldwide market

Strategic partnership will be led by Aphria Germany, with first product expected by early 2019

Aug 27, 2018 04:08 pm ET

Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia's adult-use cannabis market

Aphria's portfolio of adult-use brands and products will be available at the NSLC's cannabis retail locations and online through the NSLC's website starting October 17

Aug 21, 2018 10:09 am ET

Aphria signs agreement with OCS to supply 59 SKUS for the adult-use market in Ontario

The company will provide a wide-range of high-quality, branded adult-use cannabis products for sale online in Ontario

Aug 14, 2018 07:00 am ET

Perennial and Aphria Sign LOI to Establish Joint Venture to Develop New, Consumer-Centric, Cannabis-Infused Products and Brands for the Canadian Market

Perennial Inc. (“Perennial”), a subsidiary of DATA Communications Management Corp. (TSX:DCM) (“DCM”), and Aphria Inc. (TSX:APH and US OTC:APHQF) (“Aphria”) are pleased to announce they have signed a Letter of Intent to form a joint venture (the “JV”) to collaborate on the development of new products, brands and product categories that will drive the evolution of the Canadian adult-use cannabis market. It is expected that a definitive agreement formalizing the joint venture will be finalized within the coming weeks.

Aug 08, 2018 07:00 am ET

Aphria to provide coast-to-coast retail distribution to B.C.-based premium cannabis producer We Grow

Canada-wide sales distribution network will support Aphria's expanding portfolio of in-house and partner adult-use brands

Aug 01, 2018 07:00 am ET

Aphria Records Revenue Increase of 17% in Quarter and 81% Year Over Year

Adjusted gross margin increases to 78.7% of revenue as cash costs per gram remain below $1.00Industry leading eleventh consecutive quarter of positive Adjusted EBITDA from ACMPR operations1

Jul 31, 2018 07:00 am ET

Aphria Secures $25 Million Loan from WFCU Credit Union

LEAMINGTON, ON, July 31, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it is has secured $25 million in debt financing from WFCU Credit Union ("WFCU"). The five-year term loan bears interest at 4.68%, has a 15-year amortization and was entered into on July 27, 2018. This is the second round of debt-financing secured by the Company from WFCU, having previously secured a $25 million five-year loan on May 9, 2017.

Jul 26, 2018 07:00 am ET

Aphria Completes Largest Export Shipment to Date to Medlab Australia

Medlab is using Aphria's medical cannabis (CBD and THC) in human trials for advanced cancer pain

Jul 25, 2018 07:00 am ET

Aphria to Announce Fourth Quarter Results on August 1, 2018

LEAMINGTON, ON, July 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its fourth quarter results for 2018 on August 1, 2018.

Jul 23, 2018 04:52 pm ET

Aphria provides update on investments

Aphria secures 18-month lock-up agreement on divestiture of Liberty stockStrategic Investment in Fire & Flower

Jul 17, 2018 08:34 am ET

Scythian Announces Strategic Sale of Latin American and Caribbean Assets in $193,000,000 Deal to Aphria

Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that it has entered into a strategic deal with Aphria Inc. (TSX:APH) (“Aphria”), a leading global cannabis...

Jul 17, 2018 08:30 am ET

Aphria plans for global cannabis leadership with international expansion acquiring leading assets in Latin America and the Caribbean

Aphria medical brands to gain exposure to over 300 million people, roughly 9 times the size of Canada

Jul 12, 2018 02:27 pm ET

Aphria Signs MOU to Supply More Than 5,000 Kg of Cannabis to British Columbia's Retail Cannabis Market

The Company's comprehensive portfolio of adult-use brands and products will be sold online and at licensed retailers across the province

Jul 09, 2018 09:00 am ET

Aphria to Announce Fourth Quarter Results on August 1, 2018

LEAMINGTON, ON, July 9, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its fourth quarter results for 2018 on August 1, 2018.

Jul 05, 2018 07:30 am ET

Aphria Signs Agreement with AGLC to Supply Adult-Use Cannabis to Alberta

The Company's portfolio of adult-use brands will be available for sale in licensed retailers across the province

Jul 05, 2018 07:00 am ET

Aphria completes divestiture of its ownership interest in Copperstate Farms, realizes gain of approximately $8.8 million

LEAMINGTON, ON, July 5, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) announces that it has successfully completed the divestiture of the Company's ownership interest in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively "Copperstate"), previously announced on February 2, 2018. Aphria's original investment was approximately $11.1 million ($8.2 million USD). Aphria received $20 million as part of the divestiture, realizing a gain of approximately $8.8 million on the sale.

Jun 29, 2018 07:00 am ET

Aphria Signs Supply Agreement with MBLL to Supply Up to 2.7 Million Grams of Cannabis to the Manitoba Adult-Use Market

The Company will provide a wide range of adult-use brands and products to be sold at licensed retailers across the province

Jun 28, 2018 09:46 am ET

Aphria Announces Closing of Bought Deal Financing

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

Jun 21, 2018 07:00 am ET

Aphria's Malta-based subsidiary, ASG Pharma, receives first import license for cannabis issued by the Malta Medicines Authority

ASG Pharma is poised to become Aphria's processing, manufacturing and distribution hub for the European continent

Jun 20, 2018 07:00 am ET

Aphria Applauds Passage of Bill C-45, a Historic Milestone for Canada and the Cannabis Industry

With annualized production of 255,000 kg, Aphria is well-prepared to meet the demand of the new adult-use market and our medical cannabis patients

Jun 15, 2018 07:00 am ET

Aphria Appoints Former Southern Glazer's Executive Joel Toguri as Vice President of Sales

LEAMINGTON, ON, June 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced the appointment of Joel Toguri as Vice President of Sales effective on June 18, 2018. Mr. Toguri joins the Company from Southern Glazer's of Canada ("Southern Glazer's"), where he was Vice President of Sales and Operations since 2013.

Jun 08, 2018 02:44 pm ET

Aphria Welcomes Passage of Bill C-45 in Senate, Ready to Meet Demand for Adult-Use Cannabis in Canada

LEAMINGTON, ON, June 8, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today provided the following statement in reaction to the passage of Bill C-45, the Cannabis Act, in the Senate of Canada:

Jun 07, 2018 08:08 am ET

IIROC Trade Resumption - SMU.UN; PL; ZYME; APH; NVU.UN

TORONTO, June 7, 2018 /CNW/ - Trading resumes in:

Jun 06, 2018 04:18 pm ET

Aphria Announces $225 Million Bought Deal

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. (“Aphria” or the “Company”) (TSX:APH) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf...

Jun 06, 2018 03:23 pm ET

IIROC Trading Halt - APH

TORONTO, June 6, 2018 /CNW/ - The following issues have been halted by IIROC:

Jun 06, 2018 07:00 am ET

Aphria to build state-of-the art Extraction Centre of Excellence

Aphria increases production capacity to 255,000 kgs

May 28, 2018 07:00 am ET

Aphria Forms Landmark Venture with South African Company Verve Group of Companies

The Venture will focus on expanding the Company's footprint in established regulated cannabis markets in Africa.

May 17, 2018 08:00 am ET

Aphria's German subsidiary, Nuuvera Deutschland, acquires interest in Berlin-based Shöneberg Hospital

Acquisition lays the foundation for nation-wide research, education and treatment activities for pain treatment centers throughout Germany

May 17, 2018 07:00 am ET

Aphria selects Great North Distributors, a Canadian subsidiary of Southern Glazer's Wine & Spirits, for Canada-wide distribution of adult-use cannabis

Great North Distributors to be Aphria's exclusive cannabis representative in Canada

May 17, 2018 07:00 am ET

Aphria Selects Great North Distributors, a Canadian Subsidiary of Southern Glazer’s Wine & Spirits, for Canada-Wide Distribution of Adult-Use Cannabis

Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) and Great North Distributors, Inc. (“Great North Distributors”), a wholly-owned Canadian subsidiary of

May 16, 2018 09:14 am ET

Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia

Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Colombian-based ColCanna SAS (“ColCanna”), a company that Scythian is in the process of acquiring, has...

May 16, 2018 08:58 am ET

Aphria signs exclusive agreement with Colombia-based Colcanna SAS to supply medical cannabis in Colombia

LEAMINGTON, ON, May 16, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed an exclusive supply agreement with Colcanna SAS ("Colcanna") a Colombia-based pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical cannabis, medical products and derivatives in Colombia.

Apr 25, 2018 09:06 am ET

Scythian Biosciences Corp. Announces the Appointment of European Cannabis Leader Rob Reid of Prohibition Partners as CEO

– In addition Scythian announces Liberty Health Sciences CEO George Scorsis as Chairman of the Board and Welcomes Back Rogers Communications Executive Roger Rai to the Board

Apr 25, 2018 07:00 am ET

Aphria Appoints Chief Commercial Officer and Chief Legal Officer Adding Depth to Leadership Team and Implements New Governance Initiatives

Jakob Ripshtein to become Aphria's first Chief Commercial OfficerChristelle Gedeon appointed Chief Legal Officer

Apr 24, 2018 07:37 am ET

Aphria completes first medical cannabis shipment to Australia-based partner Althea

Aphria delivers branded cannabis oil and dried flower products to Althea

Apr 23, 2018 07:00 am ET

Broken Coast Cannabis Nearly Doubles Production Capacity with Health Canada Approval of Phase III Expansion

LEAMINGTON, ON, April 23, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its subsidiary, Broken Coast Cannabis ("Broken Coast"), has received a license amendment from Health Canada that provides Broken Coast with an additional 18,000 square feet of production space as part of its Phase III expansion, bringing total production space to 44,000 square feet. As a result of the amendment, Broken Coast's production capacity will nearly double to 4,500 kg annually.

Apr 18, 2018 09:02 am ET

Scythian Announces ABP S.A.’s First Purchase Order with Aphria Inc.

– Order to Supply World Renowned Pediatric Hospital for Research and Education –

Apr 17, 2018 11:00 am ET

Aphria Launches Solei, its First Adult-Use Brand, Designed for the Modern Cannabis Consumer

Solei offers a thoughtfully curated assortment of products and strains designed to enhance a wide variety of individual and shared experiences

Apr 16, 2018 07:00 am ET

Aphria Inc. - Revenue Growth and Sub $1.00 Cash Cost per Gram Metric Highlight Quarter

Tenth consecutive quarter of positive adjusted EBITDA2 Significant levels of cash available for deployment in attractive investment opportunities

Apr 11, 2018 07:00 am ET

Aphria finalizes three-year supply agreement with the SAQ to provide up to 12,000 kg of cannabis annually to Quebec market

LEAMINGTON, ON, April 11, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or US OTC: APHQF) today announced that it has finalized the previously announced supply agreement with the Société des alcools du Québec ("SAQ"). The three-year agreement for up to 12,000 kg annually guarantees a supply of high-quality, safe and clean cannabis products for sale in the Quebec adult-use market, through the Société québécoise du cannabis' (SQDC) retail outlets and e-commerce platform.

Apr 10, 2018 08:00 am ET

Aphria to Announce Third Quarter Results on April 16, 2018

LEAMINGTON, ON, April 10, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its third quarter results for 2018 on April 16, 2018.

Apr 05, 2018 07:00 am ET

Aphria provides update on Part III expansion operations

First harvest from Part III expected to take place at the end of April

Mar 27, 2018 07:00 am ET

Aphria launches Aphria International and provides updates on worldwide operations

Recently-acquired Nuuvera to be renamed Aphria International Aphria International will focus on expanding the Company's footprint in established regulated cannabis markets outside of Canada

Mar 23, 2018 10:31 am ET

Aphria and Nuuvera Announce Closing Of Arrangement

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Mar 21, 2018 09:00 am ET

Aphria signs exclusive agreement with Argentina-based importer to supply medical cannabis in Argentina

LEAMINGTON, ON, March 21, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed an exclusive supply agreement with an Argentinan based pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical products and derivatives in Argentina. The importer is currently securing an import license for cannabis in Argentina.

Mar 20, 2018 05:47 pm ET

Nuuvera announces shareholder approval of plan of arrangement with Aphria Inc.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Mar 16, 2018 07:00 am ET

Aphria receives third-party independent GMP certification of Leamington growing and processing facilities

Aphria is the first Canadian Licensed Producer to be certified by SGS to the USFDA standards for Active Pharmaceutical Ingredients and Finished Pharmaceuticals

Mar 15, 2018 07:00 am ET

Aphria's Australian-based partner Althea receives Medical Cannabis License for cultivation

Aphria maintains a 25% ownership interest in Althea and existing supply agreement

Mar 13, 2018 07:00 am ET

Aphria More Than Triples Production Capacity with Health Canada Approval for Part III Expansion

Annual production capacity increases to 30,000 kg

Mar 12, 2018 04:30 pm ET

Scythian Biosciences Announces 4-For-1 Stock Split and Appointment of Vic Neufeld as New Chairman of the Board of Directors

TORONTO, March 12, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announces that, further to its press release on March 9, 2018 whereby the Company announced shareholder approval of...

Feb 20, 2018 06:00 am ET

Aphria Amends Arrangement Agreement with Nuuvera

LEAMINGTON, ON, Feb. 20, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) announces today that it has entered into an amending agreement (the "Amendment") to the previously announced arrangement agreement (the "Arrangement Agreement") dated January 28, 2018 between Aphria and Nuuvera Inc. ('Nuuvera") whereby the Company and Nuuvera have agreed to amend the Arrangement Agreement to reduce both the required level of unrestricted cash and the consideration payable to holders of Nuuvera's common shares (each a "Nuuvera Share"). The consideration under the Amendme

Feb 14, 2018 05:45 am ET

Aphria signs letter of intent with SAQ to supply up to 12,000 kg of cannabis annually to Quebec market

Aphria becomes one of the first suppliers of adult-use cannabis to La Belle Province

Feb 13, 2018 09:18 am ET

Scythian Biosciences Announces Closing of $28.7 Million Financing with Aphria Inc. as Lead Investor

TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has today closed its previously announced “bought deal” short form prospectus offering, including the full...

Feb 13, 2018 07:00 am ET

Aphria announces closing of Broken Coast Cannabis acquisition

LEAMINGTON, ON, Feb. 13, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has closed the previously announced acquisition (the "Transaction") of Broken Coast Cannabis Inc. ("Broken Coast"), a leading premium cannabis producer located in British Columbia, acquiring 99.86% of all of the issued and outstanding Class A common shares.

Feb 05, 2018 06:00 am ET

Aphria begins to divest of its equity investment in passive US assets

After the initial divesture, Aphria maintains 28.1% interest in Liberty and 2 of 5 directors

Feb 02, 2018 07:00 am ET

Aphria and Liberty Health Sciences Announce Definitive Agreement for Sale of Aphria's Investment in Copperstate Farms to Liberty

LEAMINGTON, ON and TORONTO, Feb. 2, 2018 /CNW/ - Aphria Inc. (TSX: APH or OTCQB: APHQF) ("Aphria") and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) ("Liberty") jointly announce that they have entered into a definitive agreement (the "Agreement") with respect to the sale (the "Transaction") of Aphria's subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively "Copperstate") to Liberty for a purchase price of $20 million ("Purchase Price").

Feb 01, 2018 10:32 am ET

Aphria considers strategic alternatives for its US cannabis interests

LEAMINGTON, ON, Feb. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) confirms today that the Company is currently exploring and considering strategic alternatives with respect to its US cannabis related interests, including the possible divestiture of its investments to strategic, long-term and committed investors in the cannabis industry.

Jan 29, 2018 06:00 am ET

Global leader in medical cannabis created by Aphria and Nuuvera combination

Combination capitalizes on Nuuvera's expansive international footprint, expanding network into Europe, Africa and the Middle East Transaction combines Aphria's low-cost, high quality cultivation at scale with Nuuvera's expertise in cannabis processing, and provides access to Nuuvera's state-of-the-art testing and extraction facilities Expected be accretive to Aphria shareholders in first full fiscal year after close on an earnings per share basis Brings together two strong management teams with highly complementary expertise and international relationships Investment community conference ca

Jan 19, 2018 07:30 am ET

Nuuvera and Aphria finalize offtake agreement for extra 60,000 kgs of cannabis production

LEAMINGTON, ON, Jan. 19, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV: NUU) and Aphria Inc. ("Aphria") (TSX: APH & US OTC QB: APHQF) announced today that they have executed a previously announced definitive offtake agreement for 60,000 kgs of cannabis production.

Jan 17, 2018 11:22 am ET

Cannabis Wheaton Announces International Supply Agreement With Aphria

VANCOUVER, British Columbia, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V:CBW) (“Wheaton Income” or “Wheaton” or the “Company”) is pleased to announce that it has entered into a binding interim supply agreement...

Jan 15, 2018 07:00 am ET

Aphria strengthens portfolio with acquisition of leading West Coast producer Broken Coast

With Broken Coast, Aphria becomes the largest Canadian EBITDA generating Licensed ProducerCreates leading cross-Canada platform, with scaled low cost greenhouse operations in Ontario and award-winning premium indoor BC production

Jan 15, 2018 06:00 am ET

Aphria Continues Expansion into Australia with Strategic Investment in Althea Company Pty Ltd.

Investment and supply agreement enhances Aphria's foothold into international markets

Jan 10, 2018 07:00 am ET

Aphria increases revenue 39% and Kilograms(1) sold 45% in quarter

Ninth consecutive quarter of positive adjusted EBITDA from operations2

Jan 08, 2018 07:00 am ET

Aphria secures additional 120,000 kgs of expected annual cannabis production for January 2019(1)

Aphria enters strategic relationship with local growerAccelerates capacity increase by over one year

Jan 03, 2018 08:30 am ET

Aphria Announces Closing of Bought Deal Financing

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

Dec 29, 2017 12:30 pm ET

IIROC Trade Resumption - Aphria Inc.

Toronto, Ontario--(Newsfile Corp. - December 29, 2017) - Trading resumes in:

Dec 29, 2017 12:29 pm ET

IIROC Trade Halt - Aphria Inc.

Toronto, Ontario--(Newsfile Corp. - December 29, 2017) - The following issues have been halted by IIROC:

Dec 29, 2017 11:39 am ET

IIROC Trade Resumption - WEED: APH

TORONTO, Dec. 29, 2017 /CNW/ - Trading resumes in:

Dec 29, 2017 11:31 am ET

IIROC Trading Halt - WEED; APH

TORONTO, Dec. 29, 2017 /CNW/ - The following issues have been halted by IIROC:

Dec 21, 2017 07:00 am ET

DOJA Cannabis and Tokyo Smoke announce merger and strategic investment from Aphria Inc.

Two Canadian cannabis lifestyle brands join forces in a transformational transaction, bringing together industry leading management teams, British Columbia curated handcrafted cannabis production, a...

Dec 21, 2017 06:00 am ET

Aphria Strengthens Leadership Position in Recreational Cannabis with $10 Million Investment in Toyko Smoke-DOJA Combination

Investment creates additional platform on which to build portfolio of premium West Coast cannabis products

Dec 13, 2017 08:02 am ET

Aphria Inc. Announces $100 Million Bought Deal

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX:APH) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on...

Dec 11, 2017 07:35 am ET

Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com

SAN ANTONIO, Dec. 11, 2017 /CNW/ -- Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international, vertically-integrated medical cannabis company, today announced that the Dec. 7th investor presentation and webcast from Alternate Health CEO Dr. Michael Murphy is now available for on-demand viewing at VirtualInvestorConferences.com.

Dec 11, 2017 07:35 am ET

Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com

SAN ANTONIO, Dec. 11, 2017 /PRNewswire/ -- Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international, vertically-integrated medical cannabis company, today announced that the Dec. 7th investor presentation and webcast from Alternate Health CEO Dr. Michael Murphy is now available for on-demand viewing at VirtualInvestorConferences.com.

Dec 08, 2017 04:15 pm ET

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

Results of the Quarterly Review of the S&P/TSX Composite Index

Dec 04, 2017 04:01 pm ET

IIROC Trade Resumption - Aphria Inc.

Toronto, Ontario--(Newsfile Corp. - December 4, 2017) - Trading resumes in:

Dec 04, 2017 03:52 pm ET

IIROC Trade Halt - Aphria Inc.

Toronto, Ontario--(Newsfile Corp. - December 4, 2017) - The following issues have been halted by IIROC:

Dec 04, 2017 12:13 pm ET

Tokyo Smoke wins Best Brand at inaugural Canadian Cannabis Awards

Tokyo Smoke, a leading cannabis lifestyle brand, was awarded Brand of the Year at the inaugural Canadian Cannabis Awards gala, held on Nov. 30 in Toronto. The prestigious award recognizes Tokyo Smoke's impact on the industry over the past year,...

Nov 29, 2017 03:25 pm ET

Tokyo Smoke announces President, VP of Strategy and Marketing, Head of Content

Tokyo Smoke is pleased to announce the appointment of Brian Polsinello as President, alongside Felicia Snyder as Vice President, Strategy and Marketing, and Odessa Paloma Parker as Head of Content, joining a strong roster of talent that has helped...

Nov 23, 2017 07:00 am ET

Aphria Achieves Next Milestone in International Expansion Strategy with Receipt of Dealer's License

Aphria now able to export approved cannabis products to international markets

Nov 21, 2017 11:41 am ET

Tokyo Smoke Beltline in Calgary opens December 7

Tokyo Smoke continues its ambitious national retail expansion by announcing that the Calgary, Alberta retail location will open Thurs., Dec. 7, marking the brand's first shop outside of Ontario. Tokyo Smoke Beltline (1205 1st St. SW) will open in...

Nov 07, 2017 10:04 am ET

Aphria Announces Closing of Bought Deal Financing

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

Oct 27, 2017 09:00 am ET

Shareholders elect Renah Persofsky and Shawn Dym to Aphria's Board of Directors

LEAMINGTON, ON, Oct. 27, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) is pleased to announce that Renah Persofsky and Shawn Dym were elected as new directors at the Company's annual general and special meeting held on October 25, 2017.

Oct 24, 2017 08:30 am ET

Aphria Completes First Medical Cannabis Oil (CBD/THC) Shipment to Australia-based Medlab

MATERIAL RECEIVED IN AUSTRALIA, PRE-CLINICAL TRIAL WORK COMMENCING

Oct 24, 2017 08:30 am ET

Tokyo Smoke closes on upsized $6 million Series B round

Tokyo Smoke, an award-winning lifestyle brand that brings sophistication and design to the cannabis space, is pleased to confirm the final closing of its oversubscribed Series B funding of approximately $6 million CAD. The funds will be allocated to...

Oct 23, 2017 08:00 am ET

Aphria engages in positive dialogue with Toronto Stock Exchange

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

Oct 20, 2017 03:21 pm ET

UPDATE - Van der Pop to launch branded cannabis with WeedMD in November 2017

Van der Pop (VdP), North America's leading female-focused cannabis brand, is pleased to announce its two branded strains of cannabis will be available for purchase by the end of November, in partnership with WeedMD, a federally-licensed producer and...

Oct 19, 2017 03:50 pm ET

Van der Pop to launch branded cannabis with WeedMD in November 2017

Oct 17, 2017 08:24 am ET

Aphria Inc. Announces $80 Million Bought Deal

Oct 17, 2017 08:15 am ET

Aphria welcomes new CSA disclosure guidelines, provides comment on TSX staff notice

LEAMINGTON, ON, Oct. 17, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) responded today to both the Canadian Securities Administrators ("CSA") Staff Notice 51-352 – Issuers with U.S. Marijuana-Related Activities and the Toronto Stock Exchange ("TSX") guidance on Section 306, Section 325 and Part VII of the TSX Company Manual, issued on October 16, 2017.

Oct 13, 2017 09:00 am ET

Aphria reports strong performance in Q1 2018, including record revenue and grams sold

Lowered cash costs for the quarter, furthering commitment to being a low-cost producerFour-part greenhouse expansion on track for completion in 2018, poised to meet expected recreational demand

Oct 05, 2017 09:00 am ET

New Proposed Federal Tax Plan for Cannabis Underscores Need for Low Cost Producers

LEAMINGTON, ON, Oct. 5, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) provided the following statement today regarding the federal government's announcement on Tuesday, October 3, 2017, relating to the proposed $1.00 per gram excise tax on legal cannabis in Canada.

Sep 08, 2017 07:11 pm ET

Aphria Welcomes Ontario Government's Commitment to Providing Safe and Sensible Access to Recreational Cannabis

Company has a sound recreational strategy, uniquely positioned to meet expected surge in demand

Aug 21, 2017 08:00 am ET

Aphria and Liberty Respond to TMX Group Statement Regarding Regulatory Engagement

TORONTO, Aug. 21, 2017 /CNW/ - Aphria Inc. (TSX: APH) ("Aphria") and Liberty Health Sciences Inc. (CSE: LHS) ("Liberty") jointly respond to the TMX Group Statement Regarding Regulatory Engagement.

Aug 17, 2017 10:43 am ET

Tokyo Smoke Calgary to open in fall 2017, first in nationwide roll-out

Tokyo Smoke is excited to announce its expansion into the Prairies, with six new retail locations slated to open over the next two years. Starting with downtown Calgary in fall 2017, Tokyo Smoke's retail and coffee shops will also see additional...

Aug 15, 2017 09:00 am ET

Aphria Announces $11.5 Million Strategic Investment In Scientus Pharma

Innovative extraction process opens door to future cannabinoid based medical products

Aug 10, 2017 09:00 am ET

Tokyo Smoke partners with Aphria to launch medical cannabis

Tokyo Smoke breaks ground by introducing four medical cannabis strains in collaboration with Aphria Inc., one of Canada's largest licensed producers of medical marijuana. This is the first time a Canadian consumer brand will partner with a Licensed...

Aug 09, 2017 09:00 am ET

Aphria Announces Global Strategic Partnership With Emerging International Leader Nuuvera Corp.

Aphria once again delivers shareholder value by monetizing its intellectual property

Aug 03, 2017 08:32 am ET

Tokyo Smoke closes on $4 million of Series B funding

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.Tokyo Smoke, an award-winning lifestyle brand aiming to bring sophistication and design to the cannabis space, is excited to confirm the first closing...

Jul 12, 2017 08:00 am ET

EBITDA increases 181% in the quarter, exceeding $2.8 million

Aphria Inc. ("Aphria" or the "Company") (TSX: APH)(OTCQB: APHQF) today reported its results, for the four quarter and year ended May 31, 2017. All amounts are expressed in Canadian dollars.

Jul 12, 2017 07:58 am ET

EBITDA increases 181% in the quarter, exceeding $2.8 million

Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) today reported its results, for the four quarter and year ended May 31, 2017. All amounts are expressed in Canadian dollars....

Jul 04, 2017 10:00 am ET

Tokyo Smoke to open Canadian flagship retail store on Queen Street West July 20

Tokyo Smoke is excited to announce the opening of a flagship Canadian retail location and cafe on Thurs., July 20 at 668 Queen St. W., in the heart of Toronto's vibrant West Queen West neighbourhood. Tokyo Smoke, Canada's leading cannabis and...

Jul 04, 2017 07:58 am ET

Aphria Inks Major Wholesale Supply Agreement With Scientus Pharma, Health Canada Licensed Dealer

Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF), through its subsidiary Pure Natures Wellness Inc. (o/a Aphria), is pleased to announce that it entered into a major wholesale supply agreement with HydRx Farms, Ltd. (o/a Scientus...

Jun 19, 2017 03:36 pm ET

Aphria confirms working partnership with LiUNA Local 625

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria") (TSX:APH)(OTCQB:APHQF) confirms it has entered into a working partnership with LiUNA Local 625 (located in Essex/Kent...

Jun 15, 2017 03:58 pm ET

Aphria Launches First Partnership with Major North American Union

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Today, Aphria Inc. (Aphria) (TSX:APH)(OTCQB:APHQF) announced its first collaborative initiative with Labourers' International Union of North...

Jun 13, 2017 07:51 pm ET

Kitrinor Metals Inc. and Scythian Biosciences Inc. Announce Signing of Business Combination Agreement

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws....

May 24, 2017 07:58 am ET

Aphria Advances Growth in US Medical Cannabis Market With Completion of Strategic Investment in DFMMJ, and Exclusive Management Agreement With Chestnut Hill Tree Farm LLC

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) and Securecom Mobile Inc. ("Liberty") (CSE:SCM) are pleased to announce the...

May 15, 2017 07:58 am ET

Aphria Triples Production Capacity With Approval From Health Canada for Part II Expansion

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) is pleased to announce that the Company has received a license amendment...

May 11, 2017 04:15 pm ET

Aphria Announces 'Seed to Sale Certified' Quality Promise

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) today unveiled its Seed to Sale Certified quality promise as part of its...

May 09, 2017 09:36 am ET

Aphria Announces Closing of Bought Deal Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) is pleased to announce it has closed its short form prospectus offering, on a...

May 09, 2017 07:58 am ET

Aphria Announces Closing of $25 Million Secured Term Loan

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) announced that it has closed on its previously announced five-year, $25 million...

Apr 20, 2017 10:28 am ET

IIROC Trade Resumption - APH

TORONTO, April 20, 2017 /CNW/ - Trading resumes in:

Apr 20, 2017 09:33 am ET

IIROC Trading Halt - APH

TORONTO, April 20, 2017 /CNW/ - The following issues have been halted by IIROC:

Apr 20, 2017 09:15 am ET

Aphria Raises $100 Million to Fund Continued Expansion of Production Capacity and Other Strategic Opportunities

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF), a Health Canada Licensed Producer of medical cannabis products, announced today...

Apr 19, 2017 08:00 am ET

Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec

Tetra Bio-Pharma Inc. ("Tetra") (CSE: TBP) (OTCQB: GRPOF) and Aphria Inc. ("Aphria") (TSX: APH) (OTCQB: APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.

Apr 19, 2017 07:58 am ET

Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec

Tetra Bio-Pharma Inc. ("Tetra") (CSE:TBP) (OTCQB:GRPOF) and Aphria Inc. ("Aphria") (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec. Tetra and...

Apr 13, 2017 04:02 pm ET

Aphria Welcomes New Federal Recreational Cannabis Legislation

Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF), a Health Canada Licensed Producer of medical cannabis products, comments on the proposed Cannabis Act announced today. Vic Neufeld, Chief Executive Officer of Aphria, said:...

Apr 13, 2017 04:02 pm ET

Aphria Welcomes New Federal Recreational Cannabis Legislation

Aphria Inc. ("Aphria" or the "Company") (TSX: APH)(OTCQB: APHQF), a Health Canada Licensed Producer of medical cannabis products, comments on the proposed Cannabis Act announced today.

Apr 13, 2017 08:00 am ET

Aphria records fifth consecutive quarter of profitability

Aphria Inc. ("Aphria" or the "Company") (TSX: APH)(OTCQB: APHQF) today reported its third quarter results, for the three and nine months ended February 28, 2017. All amounts are expressed in Canadian dollars.

Apr 13, 2017 07:58 am ET

Aphria records fifth consecutive quarter of profitability

Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) today reported its third quarter results, for the three and nine months ended February 28, 2017. All amounts are expressed in Canadian dollars....

Apr 11, 2017 11:18 am ET

IIROC Trade Resumption - APH

TORONTO, April 11, 2017 /CNW/ - Trading resumes in:

Apr 11, 2017 11:15 am ET

IIROC Trading Halt - APH

TORONTO, April 11, 2017 /CNW/ - The following issues have been halted by IIROC:

Apr 07, 2017 11:45 am ET

Aphria Inc. Opens the Market

TORONTO, April 7, 2017 /CNW/ - Vic Neufeld, Chief Executive Officer, Aphria Inc. (APH), joined Shaun McIver, Chief Client Officer, Equity Capital Markets, TMX Group, to open the market. Located in Leamington, Ontario, Aphria Inc., is a Health Canada Licensed Producer of medical cannabis. Aphria provides pharma-grade medical cannabis and patient care while balancing patient economics and returns to shareholders. Aphria Inc. graduated from TSX Venture Exchange and commenced trading on Toronto Stock Exchange on March 22, 2017.

Apr 04, 2017 04:43 pm ET

Aphria Launches US Expansion Strategy

Mar 30, 2017 09:00 am ET

MassRoots Receives US$450,000 in Proceeds from Early Exercise of Warrant by Aphria

DENVER, March 30, 2017 /PRNewswire/ -- Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) one of the leading Canadian licensed producers of medical cannabis, and MassRoots, Inc. (OTCQB: MSRT), one of the largest technology platforms for the cannabis industry, are pleased to announce the early exercise of warrants by Aphria at US$0.90 per share for total proceeds to MassRoots of US$450,000. Aphria initially invested US$250,000 in MassRoots last fall and established a two-year exclusive partnership focused on the Canadian market.

Mar 30, 2017 08:00 am ET

MassRoots Receives US$450,000 in Proceeds from Early Exercise of Warrant by Aphria

Aphria Inc. ("Aphria" or the "Company") (TSX: APH)(OTCQB: APHQF), one of the leading Canadian licensed producers of medical cannabis, and MassRoots, Inc. (OTCQB: MSRT), one of the largest technology platforms for the cannabis industry, are pleased to announce the early exercise of warrants by Aphria at US$0.90 per share for total proceeds to MassRoots of US$450,000. Aphria initially invested US$250,000 in MassRoots last fall and established a two-year exclusive partnership focused on the Canadian market.

Mar 30, 2017 07:58 am ET

MassRoots Receives US$450,000 in Proceeds from Early Exercise of Warrant by Aphria

Mar 27, 2017 08:00 am ET

Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5%

Aphria Inc. ("Aphria" or the "Company") (TSX: APH)(OTCQB: APHQF), through its subsidiary Aphria (Arizona) Inc., is pleased to announce that it made an additional investment of $3 million (USD) in Copperstate Farms Investors, LLC ("Investors"). The investment will assist Investors in advancing its capital expenditure program related to extractions, lighting and power generation. This investment increases Aphria's membership units in Investors from 10% to 18.5% of those issued.

Mar 27, 2017 07:58 am ET

Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5%

Mar 21, 2017 08:00 am ET

Aphria Continues Success Story With TSX Listing

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH)(OTCQB: APHQF), a Health Canada Licensed Producer of medical cannabis products, today announced that the common shares (the "Common Shares") of the Company will begin trading on the Toronto Stock Exchange ("TSX") as of the open of the market on March 22, 2017. The Common Shares will continue to trade under the symbol "APH". In conjunction with listing on the TSX, the Common Shares will be voluntarily delisted from the TSX Venture Exchange prior to the commencement of trading on March

Mar 21, 2017 07:58 am ET

Aphria Continues Success Story With TSX Listing

Mar 15, 2017 06:22 pm ET

Aphria Issues Common Shares Pursuant to Shares for Services Agreement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)(OTCQB:APHQF) announces that the Company has entered into a consulting agreement (the...

Mar 08, 2017 05:17 pm ET

Aphria Affirms Its Commitment to Producing Safe Medical Cannabis 100% Free of Chemical Pesticides

In light of recent media coverage, Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)(OTCQB:APHQF) today issued the following statement with respect to its ongoing commitment to providing pharmaceutical-grade cannabis that is free of chemical...

Mar 08, 2017 05:17 pm ET

Aphria Affirms Its Commitment to Producing Safe Medical Cannabis 100% Free of Chemical Pesticides

In light of recent media coverage, Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH)(OTCQB: APHQF) today issued the following statement with respect to its ongoing commitment to providing pharmaceutical-grade cannabis that is free of chemical pesticides.

Feb 24, 2017 09:21 am ET

Aphria Announces Closing of Bought Deal Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce it has closed its short form prospectus offering,...

Feb 23, 2017 09:07 am ET

Green Acre Capital Fund Secures Lead Order for Cannabis Investments

TORONTO, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Green Acre Capital (“GAC”) today announced the first close of Green Acre Capital Fund I, dedicated to investments in the Canadian legal cannabis industry. The Fund remains open and on pace to raise the targeted amount of $25 million in Q1 2017....

Feb 06, 2017 08:21 am ET

Aphria receives conditional approval to graduate to the TSX

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange and list its common shares...

Feb 06, 2017 08:21 am ET

Aphria receives conditional approval to graduate to the TSX

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH) (OTCQB: APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange and list its common shares on the TSX.

Feb 06, 2017 08:12 am ET

Aphria Inc. Announces $50 Million Bought Deal

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATESAphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH) (OTCQB: APHQF) is pleased to announce that it has entered into an agreement with Clarus...

Jan 17, 2017 02:27 pm ET

Tokyo Smoke raises $3 million in Series A funding

Tokyo Smoke, a premium cannabis-oriented lifestyle brand, has become the first Canadian cannabis consumer brand to raise capital, and oversubscribed on its first round of fundraising. Strong investment interest in the burgeoning start-up resulted in...

Jan 16, 2017 08:00 am ET

Aphria's Vision to be Reality - Part IV expansion project to increase greenhouse growing space to 1 million square feet

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH)(OTCQB: APHQF) is pleased to announce that its Board approved a $137 million capital project, known internally as Part IV expansion ("Part IV"). The project will increase Aphria's capacity under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") from 300,000 square feet to 1,000,000 square feet. In addition to the 1,000,000 greenhouse growing square feet, the Company's infrastructure will grow to over 250,000 square feet, necessary to service the expected 70,000 kilograms of

Jan 16, 2017 07:58 am ET

Aphria's Vision to be Reality - Part IV expansion project to increase greenhouse growing space to 1 million square feet

Jan 11, 2017 08:00 am ET

Aphria Reports 19% Growth in Quarterly Revenue

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH)(OTCQB: APHQF) today reported its second quarter results, for the three months ended November 30, 2016. All amounts are expressed in Canadian dollars.

Jan 11, 2017 07:58 am ET

Aphria Reports 19% Growth in Quarterly Revenue

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)(OTCQB:APHQF) today reported its second quarter results, for the three months ended November 30, 2016. All amounts are expressed in Canadian dollars....

Dec 29, 2016 04:59 pm ET

Aphria comments on today's Globe and Mail story on pesticide use and reaffirms its commitment to quality and safety

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)(OTCQB:APHQF) has always prided itself on being an industry leader when it comes to the adherence of Good Production Practices in the cultivation of medical cannabis under the Access to...

Dec 29, 2016 04:58 pm ET

Aphria comments on today's Globe and Mail story on pesticide use and reaffirms its commitment to quality and safety

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH)(OTCQB: APHQF) has always prided itself on being an industry leader when it comes to the adherence of Good Production Practices in the cultivation of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

Dec 23, 2016 08:30 am ET

REPEAT - Canabo Medical Inc. Closes $8.4 Million Equity Financing

Canabo Medical Inc. (TSX VENTURE: CMM) ("Canabo" or the "Company"), further to the Company's press release dated December 7, 2016, has closed its brokered private placement with Aphria Inc. (TSX VENTURE: APH) (OTCQB: APHQF) ("Aphria") of 6,000,000...

Dec 22, 2016 03:49 pm ET

Canabo Medical Inc. Closes $8.4 Million Equity Financing

Dec 21, 2016 08:00 am ET

Aphria Announces Final Approval of Copperstate transaction

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH)(OTCQB: APHQF) is pleased to announce that the TSX - Venture Exchange provided Final Approval of the Company's previously announced investments in Copperstate Farms, LLC and Copperstate Farms Investors, LLC.

Dec 21, 2016 07:58 am ET

Aphria Announces Final Approval of Copperstate transaction

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that the TSX - Venture Exchange provided Final Approval of the Company's previously announced investments in Copperstate Farms, LLC and Copperstate Farms...

Dec 14, 2016 08:00 am ET

Aphria continues expansion strategy

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH)(OTCQB: APHQF) announced today that the Company entered into a purchase and sale agreement to acquire 200 acres of fully serviced vacant land for $6.24 million located at 521 Mersea Road 8, Leamington, Ontario. As the land acquired does not abut the Company's existing operations, the Company requires a new site licence from Health Canada for the property. The Company anticipates the transaction closing in January 2017.

Dec 14, 2016 07:58 am ET

Aphria continues expansion strategy

Dec 06, 2016 08:30 am ET

Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials

Tetra Bio-Pharma Inc. ("Tetra Bio" or "the Company") (CSE: TBP)(CSE: TBP.CN) and (OTC PINK: GRPOF) is conducting a non-brokered private placement with Aphria Inc. (TSX VENTURE: APH)(OTCQB: APHQF) of 5,000,000 units at a price of $0.20 per unit for aggregate gross proceeds of $1,000,000. Each unit will consist of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share of the Company at a price of $0.26 per share for a period of 3 years following the closing date. The warrants are subject to an accelerated

Dec 06, 2016 08:28 am ET

Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials

Nov 30, 2016 11:14 am ET

VANCOUVER, Nov. 16, 2016 /CNW/ - The following issues have been halted by IIROC:

Nov 11, 2016 07:59 am ET

Aphria Inc. Announces $35 Million Bought Deal

Nov 03, 2016 08:30 am ET

Tetra Bio-Pharma Enters Into Medical Cannabis Supply Agreement With ACMPR Licensed Producer Aphria Inc.

Tetra Bio-Pharma Inc. ("TetraBio" or the "Company") (CSE: TBP) through its subsidiary, PhytoPain Pharma Inc. ("PPP"), is pleased to announce that it has signed a Supply Agreement with Access to Cannabis for Medical Purpose Regulations ("ACMPR") licensed producer Aphria Inc. ("Aphria") (TSX VENTURE: APH)(OTCQB: APHQF) for the supply of dried medical cannabis as an Active Pharmaceutical Ingredient (API) for PPP's inhalation cannabis product PPP001. PPP001 is a medical marijuana product that the company is developing as a prescription controlled

Nov 03, 2016 08:28 am ET

Tetra Bio-Pharma Enters Into Medical Cannabis Supply Agreement With ACMPR Licensed Producer Aphria Inc.

Nov 02, 2016 09:29 am ET

Aphria issues stock options

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH)(OTCQB: APHQF) announced that the Board of Directors of the Company granted 1,000,000 options to purchase common stock to various directors, officers, employees and consultants, at an exercise price of $3.90, for a term of three years, pursuant to the Company's incentive stock option plan.

You are here

(:APH*CA)

Business Focus: N/A